This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Metriopharm Ag. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: David Kosel: Innovator in Pharmaceutical Chemistry
Introduction
David Kosel is a notable inventor based in Leipzig, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of pharmaceutical compounds.
Latest Patents
David Kosel holds a patent for the "Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said form." This invention relates to the provision of a new crystalline form for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium. It also covers the use of this form for medical purposes, methods for producing the crystalline form, and pharmaceutical preparations that include this form. He has 1 patent to his name.
Career Highlights
David Kosel is associated with Metriopharm AG, where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing the understanding and application of pharmaceutical compounds.
Collaborations
Throughout his career, David has collaborated with notable professionals in the field, including Wolfgang Brysch and Josef Breu. These collaborations have contributed to the success of his projects and innovations.
Conclusion
David Kosel's contributions to pharmaceutical chemistry highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile